The high pressure phase transitions in KF and RbF

The high pressure B1 ? B2 transitions in KF at ~ 40 kbar and RbF at ~ 30 kbar have been studied using hydrostatic X-ray diffraction. No other transitions have been observed. The addition of the $\text{ΔV}\text{V}$ for these transitions to the already existing body of literature on B1–B2 transitions in alkali halides permits an extension of Pauling's theory to larger values of radius ratios. It also permits the modified Born criterion for predicting phase transitions to be further verified. Values of ionic radii for 8 coordination we suggest are 1.33 Å for F^?, 1.84 Å for Cr^?, 2.00 Å for Br^? and 2.27 Å for I^?.     

Improved direct measurement of leptonic coupling asymmetries with polarized Z bosons

We present final measurements of the Z boson-lepton coupling asymmetry parameters A(e), A(mu), and A(tau) with the complete sample of polarized Z bosons collected by the SLD detector at the SLAC Linear Collider. From the left-right production and decay polar angle asymmetries in leptonic Z decays we measure A(e) = 0.1544+/-0.0060, A(mu) = 0.142+/-0.015, and A(tau) = 0.136+/-0.015. Combined with our left-right asymmetry measured from hadronic decays, we find A(e) = 0.1516+/-0.0021. Assuming lepton universality, we obtain a combined effective weak mixing angle of sin (2)theta(eff)(W) = 0.230 98+/-0.000 26.     

微波消解ICP-MS测定唐古特乌头中的多种微量元素

采用HNO3-H2O2混合酸体系微波消解及电感耦合等离子体-质谱法,消解唐古特乌头样品,测定其中Mn、Fe、Co、As、Ni、Se、Cu、Zn、V和Cr共10种微量元素。探讨了样品消解的条件,通过加标回收实验,回收率为94.08%—103.50%,验证了分析数据的可靠性。结果表明,该法具有快速、简便、准确度高、能同时分析多元素的优点,结果令人满意。     

Identification of a Novel Delta Opioid Receptor Agonist Chemotype with Potential Negative Allosteric Modulator Capabilities

The δ-opioid receptor (δOR) holds great potential as a therapeutic target. Yet, clinical drug development, which has focused on δOR agonists that mimic the potent and selective tool compound SNC80 have largely failed. It has increasingly become apparent that the SNC80 scaffold carries with it potent and efficacious β-arrestin recruitment. Here, we screened a relatively small (5120 molecules) physical drug library to identify δOR agonists that underrecruit β-arrestin, as it has been suggested that compounds that efficaciously recruit β-arrestin are proconvulsant. The screen identified a hit compound and further characterization using cellular binding and signaling assays revealed that this molecule (R995045, compound 1) exhibited ten-fold selectivity over µ- and κ-opioid receptors. Compound 1 represents a novel chemotype at the δOR. A subsequent characterization of fourteen analogs of compound 1, however did not identify a more potent δOR agonist. Computational modeling and in vitro characterization of compound 1 in the presence of the endogenous agonist leu-enkephalin suggest compound 1 may also bind allosterically and negatively modulate the potency of Leu-enkephalin to inhibit cAMP, acting as a ‘NAM-agonist’ in this assay. The potential physiological utility of such a class of compounds will need to be assessed in future in vivo assays.